Clinical trial · no report yet · Phase not applicable
POP-RT
Randomized Trial of Prostate Only or Pelvic RT in High Risk Prostate Cancer
- NCT02302105 ↗
- Active not recruiting
- Tata Memorial Centre
- 79 commentary sources found
- Deep
We haven't built a report for this trial yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Commentary we found
Podcasts, YouTube videos and X posts in our index that name this trial. A report screens them, searches for more and cites what clinicians said when it is built.
| Channel | Found | |
|---|---|---|
| X threads | 70 | |
| Podcasts | 6 | |
| YouTube | 3 |
The trial
ClinicalTrials.gov- Official title
- Prospective Phase III Randomized Trial of Prostate Only or Whole Pelvic RadioTherapy in High Risk Prostate Cancer (POP-RT) Trial
- Phase
- Phase not applicable
- Status
- Active not recruiting
- Conditions
- Prostate Cancer
- Interventions
- IGRT
- Arms
- Prostate Only · Active comparator
- Whole Pelvis · Experimental
- Enrollment
- 224
- Primary outcomes
- Biochemical Disease Free Survival
- Sponsor
- Tata Memorial Centre
- Start
- Nov 25, 2011
- Primary completion
- Aug 22, 2017
- Results posted
- No
- Registry record
- NCT02302105 · updated Feb 13, 2025
Publications
linked from the registry- Maitre P, Maheshwari G, Sarkar J, Singh P, Kannan S, Dutta S, Phurailatpam R, Raveendran V, Prakash G, Menon S, Joshi A, Pal M, Arora A, Murthy V. Late Urinary Toxicity and Quality of Life With Pelvic Radiation Therapy for High-Risk Prostate Cancer: Dose-Effect Relations in the POP-RT Randomized Phase 3 Trial. Int J Radiat Oncol Biol Phys. 2024 Oct 1;120(2):537-543. doi: 10.1016/j.ijrobp.2024.03.023. Epub 2024 Mar 28. PubMed 38552989
- Murthy V, Maitre P, Kannan S, Panigrahi G, Krishnatry R, Bakshi G, Prakash G, Pal M, Menon S, Phurailatpam R, Mokal S, Chaurasiya D, Popat P, Sable N, Agarwal A, Rangarajan V, Joshi A, Noronha V, Prabhash K, Mahantshetty U. Prostate-Only Versus Whole-Pelvic Radiation Therapy in High-Risk and Very High-Risk Prostate Cancer (POP-RT): Outcomes From Phase III Randomized Controlled Trial. J Clin Oncol. 2021 Apr 10;39(11):1234-1242. doi: 10.1200/JCO.20.03282. Epub 2021 Jan 26. PubMed 33497252
- Murthy V, Maitre P, Bhatia J, Kannan S, Krishnatry R, Prakash G, Bakshi G, Pal M, Menon S, Mahantshetty U. Late toxicity and quality of life with prostate only or whole pelvic radiation therapy in high risk prostate cancer (POP-RT): A randomised trial. Radiother Oncol. 2020 Apr;145:71-80. doi: 10.1016/j.radonc.2019.12.006. Epub 2020 Jan 7. PubMed 31923712